This Roundtable supports partnerships between payer, provider and life sciences companies that can improve community health and advance health equity among racial groups and vulnerable populations. Special attention will be given to automating health data capture and assessment at the community level and addressing structural barriers to management of social determinants of longer-term population health. The goal of this Roundtable is to accelerate adoption of new models for improving the health of a community and promoting health equity for and among local populations. A crucial part of this work will include engaging with and listening to community members and partnering with key community organizations.
Each Forum Roundtable strikes a balance between near-term COVID-related challenges and long-term impact on major issues in the post-pandemic world through professional facilitation and deep subject matter expertise. The groups will develop and widely disseminate recommendations that will make an impact on provider, payer and life sciences CEOs, policymakers and thought leaders collaborating for industry-wide change.
Mandy Cohen, MD, Secretary, North Carolina Department of Health and Human Services
Pat Geraghty, President & CEO, GuideWell & Florida Blue
Rod Hochman, MD, President & CEO, Providence
Wright Lassiter, III, President & CEO, Henry Ford Health System; Chair-Elect of AHA
Mark Smith, MD, Founding President & Former CEO, California Health Care Foundation
Tim Suther, SVP & General Manager, Data Solutions, Change Healthcare
Bruce Broussard, Humana, Inc.
Carrie Byington, University of California Health
Scott Doniger, DaVita Inc.
Alex Drane, ARCHANGELS
Esther Dyson, Wellville
Matt Eyles, America's Health Insurance Plans, Inc
Kathy Feeny, Florida Blue Medicare
Pat Geraghty, Florida Blue & GuideWell
Julie Gerberding, MD, Merck & Co.
Russ Gronewald, Bryan Health
Patrice Harris, MD, eMed; formerly of American Medical Association
Nzinga Harrison, MD, Eleanor Health
Karen Ignagni, EmblemHealth
William Johnson, MD, MODA Health
Barsam Kasravi, MD, Anthem, Inc.
Kim Keck, Blue Cross Blue Shield Association
Wright Lassiter, III, Henry Ford Health System; Chair-Elect of AHA
Brian Lobley, Independence Blue Cross
Trevor Martin, Mammoth Biosciences
Stephen Mette, MD, University of Arkansas for Medical Sciences Medical Center
Bruce Meyer, Jefferson Health
Steve Miff, PhD, Parkland Center for Clinical Innovation
Shawn Morris, Privia Health
Lawrence Moss, MD, Nemours Children's Health System
Kirti Mutatkar, UnitedAg
John Naylor, Medica
Randy Oostra, Promedica Health System
Aaron Perry, Rebalanced-Life Wellness Association
Terry Shaw, Advent Health
Puneet Singh, Quartet Health
Mark Smith, MD, California Health Care Foundation
Todd Suntrapak, Valley Children's Healthcare
Tim Suther, Change Healthcare
Martha Wofford, Blue Cross Blue Shield of Rhode Island
Laurie Zephyrin, MD, The Commonwealth Fund
Work Groups are chartered by Roundtables to go deep on a key issue over a three-year period, and to make recommendations to Roundtable Fellows for pronouncements or actions that should be taken by the Roundtable, the Forum or by all CEOs. Work Groups are focused on:
Disparities in care exist throughout the healthcare system, but many payer, provider and life science organizations have not segmented their own health outcomes data by race and socioeconomic class so as to analyze the specific situations in which those disparities are occurring among their patients or members. Until they do so, they will not be able to understand the breadth and depth of the disparities or to develop strategies to address those disparities at the patient or population level. The goal of this Work Group is to enable payer, provider and life science CEOs to identify, track and manage the impact of race on prevention and clinical care.
Social determinants of health—including food, housing, and transportation—have a significant impact on health outcomes, particularly for vulnerable populations. With recent Medicare Advantage payment for some social determinants, many payer, provider and life science organizations are expanding their focus on social determinants interventions. However, these organizations have struggled to identify specific, evidence-based actions they can take internally and have largely not sought to form meaningful partnerships with community organizations that can deliver results that reduce the total cost of care and improve outcomes. Furthermore, a lack of proper infrastructure and incentive structures often impedes health care organizations from taking meaningful action. The goal of this Work Group is to identify specific scalable, replicable, and efficient best practices for payer, provider and life science CEOs to implement to address social determinants of health in collaboration with community organizations in order to meaningfully drive down the total cost of care and improve health outcomes for vulnerable populations.
Increasing Vaccine Uptake in Diverse Communities: A Working Guide for Health Care CEOs. Although data around vaccine distribution in America is sorely limited and scattered, one pattern is becoming increasingly clear – those who have been affected by COVID-19 the most are getting vaccinated the least. The working guide outlines 10 emerging best practices for creating an action plan that increases confidence and accessibility to the vaccine among the diverse communities you serve. Download the guide now.
This guide has been developed with significant input from Fellows of the Roundtable on Community Health and Advancing Health Equity.
Health Equity Roadmap for Health Care CEOs: Part I
Many organizations across the U.S. health care system have struggled to develop a methodical approach to identifying, quantifying, and taking action to address disparities impacting their patients and members. The Health Equity Roadmap for Health Care CEOs was created to provide a cross-sector guide for organizations that are seeking to develop an effective and data-driven enterprise-wide strategy to advance health equity. Download the roadmap now.